We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$971M
AUM Growth
-$19.4M
Cap. Flow
+$172M
Cap. Flow %
17.68%
Top 10 Hldgs %
24.54%
Holding
508
New
199
Increased
44
Reduced
12
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 37.12%
2 Healthcare 13.18%
3 Technology 10.4%
4 Communication Services 6.84%
5 Energy 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSSI
276
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$386K 0.04%
39,700
SCLE
277
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
$349K 0.04%
+35,900
New +$351K
AENTW icon
278
Alliance Entertainment Holding Corp Warrants
AENTW
$3.67M
$333K 0.03%
+496,367
New +$268K
EUCR
279
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$326K 0.03%
+33,090
New +$326K
RKTA
280
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$312K 0.03%
+32,200
New +$315K
GCACW
281
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$310K 0.03%
500,000
+350,000
+233% +$174K
FAZE
282
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$305K 0.03%
+31,300
New +$305K
GLSPW
283
DELISTED
Global SPAC Partners Co. Warrants
GLSPW
$275K 0.03%
+500,000
New +$196K
BENEW
284
DELISTED
Benessere Capital Acquisition Corp. Warrant
BENEW
$274K 0.03%
500,000
+447,772
+857% +$229K
SCLXW icon
285
Scilex Holding Co Warrant
SCLXW
$2.37M
$270K 0.03%
500,000
+278,706
+126% +$138K
ESSCW
286
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$269K 0.03%
959,800
+719,040
+299% +$178K
OSTRW
287
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$268K 0.03%
382,700
-22,648
-6% -$13.1K
MACC
288
DELISTED
Mission Advancement Corp.
MACC
$264K 0.03%
+27,198
New +$265K
DSAC
289
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$259K 0.03%
+26,700
New +$262K
ICUCW
290
SeaStar Medical Holding Corp Warrant
ICUCW
$250K 0.03%
500,000
GOOGL icon
291
Alphabet (Google) Class A
GOOGL
$4.08T
$244K 0.03%
2,000
KALV
292
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$240K 0.02%
+10,000
New +$262K
FOXWW
293
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$233K 0.02%
+357,987
New +$186K
MMV
294
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
$231K 0.02%
+23,400
New +$231K
VLAT
295
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$227K 0.02%
+23,489
New +$229K
SDAWW
296
SunCar Technology Group Warrant
SDAWW
$12.3M
$208K 0.02%
+671,330
New +$189K
VEEA
297
Veea Inc
VEEA
$8.93M
$200K 0.02%
+20,595
New +$202K
EQHA.WS
298
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$187K 0.02%
263,600
+39,350
+18% +$22.3K
FZT
299
DELISTED
FAST Acquisition Corp. II
FZT
$179K 0.02%
+18,328
New +$179K
CRU
300
DELISTED
Crucible Acquisition Corporation
CRU
$172K 0.02%
+17,722
New +$174K

Similar funds

Mangrove Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Mangrove Partners held 508 positions worth $971M, down 2% from $991M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Mangrove Partners deployed $172M of net new capital in Q2 2021, opening 199 new positions and adding to 44 existing holdings. Its largest new stake was Coherent Inc: 74,493 shares worth $19.7M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was GPGI Inc, an estimated $7.25M trimmed.

  • Mangrove Partners's largest Q2 2021 buy was Coherent Inc: 74,493 shares worth $19.7M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q2 2021, an estimated $32.9M increase.
  • Mangrove Partners's biggest Q2 2021 reduction was GPGI Inc, cutting an estimated $7.25M.
  • Mangrove Partners fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $17.3M.
  • Mangrove Partners's ten largest holdings make up 25% of its $971M portfolio in Q2 2021.
  • Mangrove Partners opened 199 new positions and closed 182 in Q2 2021.
  • Mangrove Partners's portfolio value fell 2% quarter-over-quarter to $971M.

Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.